Acute DOI treatment evokes dose and species-dependent locomotor effects on the elevated plus maze.

Recent evidence suggests that psychedelics hold promise in treating a range of neuropsychiatric disorders, highlighting the need to better understand their broader behavioral effects. Many animal-based behavioral assays related to mood, like anxiety…

Preview only. Read the full abstract at the source